Low-density lipoprotein size and cardiovascular risk assessment.
about
LDL electronegativity index: a potential novel index for predicting cardiovascular diseaseLipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approachesEarly Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle CellsLDL particle heterogeneity, and its association with other established cardiovascular risk factors in a young Indian industrial populationThyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort.Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases.Serum sdLDL-C and Cellular SREBP2-dependent Cholesterol Levels; is there a Challenge on Targeting PCSK9?Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation methodLow-density lipoprotein particle size in hepatic steatosis and metabolic syndromeTreatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidismLDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.Effects of wheat and oat-based whole grain foods on serum lipoprotein size and distribution in overweight middle aged people: a randomised controlled trial.Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.Discovery of diagnosis pattern of coronary heart disease with qi deficiency syndrome by the T-test-based adaboost algorithm.Circulating Lp-PLA₂ activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapyThe role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney diseaseA Simple Economical Method for Assay of Atherogenic Small Dense Low-Density Lipoprotein-Cholesterol (sdLDL-C).Dose-dependent effects of atorvastatin on myocardial infarction.LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B.Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot studyThe Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects.Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients.Conventional and Advanced Lipid Parameters in Premature Coronary Artery Disease Patients in India.The clinical relevance of low-density-lipoproteins size modulation by statins.Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.Small, dense low-density-lipoproteins and the metabolic syndrome.Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.Nigerian Honey Ameliorates Hyperglycemia and Dyslipidemia in Alloxan-Induced Diabetic Rats.Leishmania major Self-Limited Infection Increases Blood Cholesterol and Promotes Atherosclerosis DevelopmentPrepregnancy Adverse Lipid Profile and Subsequent Risk of Gestational Diabetes.Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents.Statin treatment in the elderly: how much do we know?Is it LDL particle size or number that correlates with risk for cardiovascular disease?Food consumption and the actual statistics of cardiovascular diseases: an epidemiological comparison of 42 European countriesNon-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels ＜400 mg/dL.Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up.Dietary pulp from Fructus Schisandra Chinensis supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet.Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.
P2860
Q26781851-DFF6AA67-B193-40B8-B3B1-745771B282C1Q26866207-3D3CB410-906E-47D7-B1A2-39E0F545D544Q28554645-D096B410-703E-4F7B-BD97-4B1EDBFC7414Q28834654-E4B8A80E-E8BA-4A35-9A0A-D5BC192798C7Q33309761-A65D5B23-1712-4667-960F-F8A2434FF5D1Q33717612-BD17E194-EB97-4504-8E44-1560C33401CDQ33801003-E0BC7756-E617-4927-A6E9-2EB14BF4B4EEQ33803712-F403AA90-405F-488F-BCCF-D2045384177DQ33811228-E5541554-CBD2-41FF-BA31-1C8757363A93Q33887783-805D1760-6776-4DC3-A277-874BCD61DA35Q34410638-58B295B6-BBC2-4737-B940-2E7CD1FEB20AQ34776084-46B84A2F-B9C3-4BBD-9FD6-89904CAD80CAQ34935059-98033F96-944B-4911-8246-8FA57FFD2287Q35026444-20D849F0-3837-4361-9308-D309D248AADFQ35184440-880C7EAD-E8DA-4664-B5E3-DCF545CC6CF6Q35267751-538FD377-CF04-4587-9FC7-76F6CD6D734CQ35530832-30542301-EF60-48C5-828E-CC98D4794330Q35533912-1E4561F3-7BD0-4160-B8BE-E34C4AEDF1E3Q35821913-AB4F124B-E3A2-469C-89CA-21F26B8E7F7BQ35844561-C4215CB2-8FEB-4826-B9E0-D659B407B4E3Q35849884-A854A894-9F83-4FF8-9ACD-5A8DDF39CB0AQ35854626-58041B99-0248-4608-903F-84DC5C27DC27Q36038038-174A1B99-D09C-47B8-B0C4-CA9658008FDDQ36156630-8E4B8E2E-D9C2-4E38-9F67-CB3B45DC2937Q36343410-14CB9F00-3CEB-4C0B-80F0-177107A1CD09Q36507342-274A57DF-EC02-4B9F-BCC1-6DF2E61BFFE7Q36596847-DB5225BE-6C9C-4A07-8AC1-2D730AD5B2B2Q36642327-B11B9D2A-A6AB-4C0B-B3FA-C947789F1FB6Q36675450-BA9B8F34-7D59-462B-BF28-C032EB410B99Q36731956-8B1ACBAF-E88F-47C6-95C5-E255E2D5641CQ36848288-ABDFF920-A594-4B0C-B7ED-5FCAE33E5BC0Q37057928-BD62E18D-038B-412D-A941-C36FCE10223CQ37074239-FDA587AD-4636-4452-9918-FF09130642BDQ37180162-41596720-310C-45F7-9933-34AD065EE2C1Q37244731-0CAB2BBE-6164-4B6F-A4BB-57B21288D311Q37293468-89B1A0BC-25A0-43B0-BA97-9868B08AE741Q37387229-F877E755-BEB3-484D-B80F-96CFCFA333BCQ37580358-0705FC74-D14D-43B0-9616-1A6A944BFF09Q37699702-8C5481B3-431C-4572-AF8D-1FF95584D2F0Q37716374-57C030FA-748F-45C6-B9B0-A2076308887B
P2860
Low-density lipoprotein size and cardiovascular risk assessment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Low-density lipoprotein size and cardiovascular risk assessment.
@ast
Low-density lipoprotein size and cardiovascular risk assessment.
@en
type
label
Low-density lipoprotein size and cardiovascular risk assessment.
@ast
Low-density lipoprotein size and cardiovascular risk assessment.
@en
prefLabel
Low-density lipoprotein size and cardiovascular risk assessment.
@ast
Low-density lipoprotein size and cardiovascular risk assessment.
@en
P2860
P356
P1476
Low-density lipoprotein size and cardiovascular risk assessment
@en
P2093
P2860
P356
10.1093/QJMED/HCI154
P407
P577
2006-01-01T00:00:00Z